COL6A2

Revision as of 15:10, 4 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Collagen, type VI, alpha 2
Identifiers
Symbols COL6A2 ; DKFZp586E1322; PP3610
External IDs Template:OMIM5 Template:MGI HomoloGene1392
RNA expression pattern
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Collagen, type VI, alpha 2, also known as COL6A2, is a human gene.[1]

This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene.[1]

References

  1. 1.0 1.1 "Entrez Gene: COL6A2 collagen, type VI, alpha 2".

Further reading

  • Bertini E, Pepe G (2002). "Collagen type VI and related disorders: Bethlem myopathy and Ullrich scleroatonic muscular dystrophy". Eur. J. Paediatr. Neurol. 6 (4): 193–8. PMID 12374585.
  • Lampe AK, Bushby KM (2006). "Collagen VI related muscle disorders". J. Med. Genet. 42 (9): 673–85. doi:10.1136/jmg.2002.002311. PMID 16141002.
  • Bidanset DJ, Guidry C, Rosenberg LC; et al. (1992). "Binding of the proteoglycan decorin to collagen type VI". J. Biol. Chem. 267 (8): 5250–6. PMID 1544908.
  • Saitta B, Timpl R, Chu ML (1992). "Human alpha 2(VI) collagen gene. Heterogeneity at the 5'-untranslated region generated by an alternate exon". J. Biol. Chem. 267 (9): 6188–96. PMID 1556127.
  • Dawson SJ, White LA (1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". J. Infect. 24 (3): 317–20. PMID 1602151.
  • Saitta B, Stokes DG, Vissing H; et al. (1990). "Alternative splicing of the human alpha 2(VI) collagen gene generates multiple mRNA transcripts which predict three protein variants with distinct carboxyl termini". J. Biol. Chem. 265 (11): 6473–80. PMID 1690728.
  • Saitta B, Wang YM, Renkart L; et al. (1992). "The exon organization of the triple-helical coding regions of the human alpha 1(VI) and alpha 2(VI) collagen genes is highly similar". Genomics. 11 (1): 145–53. PMID 1765372.
  • Chu ML, Pan TC, Conway D; et al. (1989). "Sequence analysis of alpha 1(VI) and alpha 2(VI) chains of human type VI collagen reveals internal triplication of globular domains similar to the A domains of von Willebrand factor and two alpha 2(VI) chain variants that differ in the carboxy terminus". EMBO J. 8 (7): 1939–46. PMID 2551668.
  • Chu ML, Conway D, Pan TC; et al. (1989). "Amino acid sequence of the triple-helical domain of human collagen type VI". J. Biol. Chem. 263 (35): 18601–6. PMID 3198591.
  • Weil D, Mattei MG, Passage E; et al. (1988). "Cloning and chromosomal localization of human genes encoding the three chains of type VI collagen". Am. J. Hum. Genet. 42 (3): 435–45. PMID 3348212.
  • Chu ML, Mann K, Deutzmann R; et al. (1987). "Characterization of three constituent chains of collagen type VI by peptide sequences and cDNA clones". Eur. J. Biochem. 168 (2): 309–17. PMID 3665927.
  • Jander R, Rauterberg J, Glanville RW (1983). "Further characterization of the three polypeptide chains of bovine and human short-chain collagen (intima collagen)". Eur. J. Biochem. 133 (1): 39–46. PMID 6852033.
  • Tillet E, Wiedemann H, Golbik R; et al. (1994). "Recombinant expression and structural and binding properties of alpha 1(VI) and alpha 2(VI) chains of human collagen type VI". Eur. J. Biochem. 221 (1): 177–85. PMID 8168508.
  • Nishiyama A, Stallcup WB (1994). "Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface". Mol. Biol. Cell. 4 (11): 1097–108. PMID 8305732.
  • Jöbsis GJ, Keizers H, Vreijling JP; et al. (1996). "Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures". Nat. Genet. 14 (1): 113–5. doi:10.1038/ng0996-113. PMID 8782832.
  • Tillet E, Ruggiero F, Nishiyama A, Stallcup WB (1997). "The membrane-spanning proteoglycan NG2 binds to collagens V and VI through the central nonglobular domain of its core protein". J. Biol. Chem. 272 (16): 10769–76. PMID 9099729.
  • Kuo HJ, Maslen CL, Keene DR, Glanville RW (1997). "Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen". J. Biol. Chem. 272 (42): 26522–9. PMID 9334230.
  • Hattori M, Fujiyama A, Taylor TD; et al. (2000). "The DNA sequence of human chromosome 21". Nature. 405 (6784): 311–9. doi:10.1038/35012518. PMID 10830953.
  • Camacho Vanegas O, Bertini E, Zhang RZ; et al. (2001). "Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI". Proc. Natl. Acad. Sci. U.S.A. 98 (13): 7516–21. doi:10.1073/pnas.121027598. PMID 11381124.
  • Scacheri PC, Gillanders EM, Subramony SH; et al. (2002). "Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype". Neurology. 58 (4): 593–602. PMID 11865138.

Template:WikiDoc Sources